Reuters logo
BRIEF-Mylan gives details on genric approval processes
2017年8月9日 / 下午3点10分 / 1 个月前

BRIEF-Mylan gives details on genric approval processes

Aug 9 (Reuters) - Mylan NV

* Says disappointed with the execution by FDA on approval process of generic Copaxone

* Says no further clinical or device-related studies are required for generic Advair approval process

* Says will be opportunistic on deal opportunities to fill product or geographic gaps Further company coverage: (Reporting By Michael Erman)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below